Transactions 10
| X |
Filed |
Traded |
Ticker |
Company |
Insider |
Title |
Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
| D |
2026-01-21 |
2025-12-11 |
JAGX |
Jaguar Health, Inc. |
CONTE LISA A |
See Remarks, Dir |
A - Grant |
$0.00 |
+28.6K |
29.3K |
+4,293% |
$0 |
| D |
2025-05-20 |
2025-05-17 |
JAGX |
Jaguar Health, Inc. |
CONTE LISA A |
CEO, Pres, Dir |
M - OptEx |
— |
+2 |
666 |
+0.3% |
— |
| D |
2024-10-10 |
2024-10-08 |
JAGX |
Jaguar Health, Inc. |
CONTE LISA A |
See Remarks, Dir |
A - Grant |
$0.00 |
+16.5K |
16.6K |
+13,639% |
$0 |
| D |
2024-05-21 |
2024-05-17 |
JAGX |
Jaguar Health, Inc. |
CONTE LISA A |
CEO, Pres, Dir |
M - OptEx |
— |
+2,695 |
7,295 |
+59% |
— |
| D |
2024-04-17 |
2024-04-05 |
JAGX |
Jaguar Health, Inc. |
CONTE LISA A |
CEO, Pres, Dir |
M - OptEx |
— |
+600 |
4,600 |
+15% |
— |
|
2023-08-14 |
2023-08-14 |
JAGX |
Jaguar Health, Inc. |
CONTE LISA A |
CEO, Pres, Dir |
A - Grant |
$0.00 |
+383.6K |
387.6K |
+9,590% |
$0 |
| D |
2023-05-19 |
2023-05-17 |
JAGX |
Jaguar Health, Inc. |
CONTE LISA A |
CEO, Pres, Dir |
M - OptEx |
— |
+2,694 |
4,000 |
+206% |
— |
| D |
2023-04-20 |
2023-04-05 |
JAGX |
Jaguar Health, Inc. |
CONTE LISA A |
CEO, Pres, Dir |
M - OptEx |
— |
+600 |
1,306 |
+85% |
— |
| D |
2022-04-06 |
2022-04-05 |
JAGX |
Jaguar Health, Inc. |
CONTE LISA A |
CEO, Pres, Dir |
M - OptEx |
— |
+45.0K |
53.0K |
+562% |
— |
| D |
2022-03-30 |
2021-09-13 |
JAGX |
Jaguar Health, Inc. |
CONTE LISA A |
CEO, Pres, Dir |
P - Purchase |
$2.51 |
+7,968 |
8,003 |
+22,766% |
+$20.0K |
Purchase
Sale
Sale after option exercise
All abbreviations